Mei Pharma earnings were -$31.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest MEIP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.6M, down 3.9% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, MEIP reported annual earnings of $17.8M, with -155.8% growth.
On MEIP's earnings call on Invalid Date, Mei Pharma (NASDAQ: MEIP) reported Q1 2025 earnings per share (EPS) of -$0.39, up 71.53% year over year. Total MEIP earnings for the quarter were -$2.57 million. In the same quarter last year, Mei Pharma's earnings per share (EPS) was -$1.37.
As of the last Mei Pharma earnings report, Mei Pharma is currently losing money. Mei Pharma's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$31.66 million, a 221.06% decrease year over year.
What was MEIP's earnings growth in the past year?
As of Mei Pharma's earnings date in Invalid Date, Mei Pharma's earnings has grown year over year. MEIP earnings in the past year totalled -$31.66 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.